Steels E, et al. Inflammopharmacology 2019 Jun;27(3):475-85.
Palmitoylethanolamide (PEA) cannot be recommended as a routine therapy for knee osteoarthritis in Australian primary care,
Tag: analgesia
Oct 11 2019
Palmitoylethanolamide (PEA) as treatment for knee osteoarthritis pain
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=1787
Recent Comments